pharma · Fatty Liver · Inflammatory Disease · GLMD
Galmed Pharmaceuticals
Galmed Pharmaceuticals patent portfolio — 11 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 16 Ze’ev Tiomkin Street, Tel Aviv, 6578317, IL, USA
- Founded
- 2000
- Employees
- 10
- Programs
- 13
- Drugs
- 5
- Patents
- 11
Galmed Pharmaceuticals patents
11 pharmaceutical patents indexed for Galmed Pharmaceuticals. 0 expire within 24 months.
Galmed Pharmaceuticals has 11 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12239712
Combination therapy for the treatment of liver disease
granted -
US 11571431
Aramchol salts
granted -
US 11197870
Treatment for hepatic fibrosis
granted -
US 11166964
Treatment for modulating gut microbiota
granted -
US 10849911
Low dose compositions of Aramachol salts
granted -
US 8975246
Bile acid or bile salt fatty acid conjugates
granted -
US 8110564
Bile acid or bile salt fatty acid conjugates
granted -
US 7501403
Bile acid or bile salt fatty acid conjugates
granted -
US 6589946
Bile salt conjugates
expired -
US 6395722
Fatty acid derivatives of bile acids and bile acid derivatives
expired -
US 6384024
Bile salt conjugates
expired
Frequently asked questions
How many patents does Galmed Pharmaceuticals have?
11 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Galmed Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.